Free Trial
LON:BELL

Belluscura (BELL) Share Price, News & Analysis

GBX 9.05 -0.20 (-2.16%)
As of 01/17/2025 07:45 AM Eastern

About Belluscura Stock (LON:BELL)

Key Stats

Today's Range
8.55
9.25
50-Day Range
8.55
10.77
52-Week Range
7
27
Volume
22,496 shs
Average Volume
158,926 shs
Market Capitalization
£15.24 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Belluscura is a UK medical device company focused on developing oxygen enrichment technology spanning broad industries and therapies. Our innovative oxygen technologies are designed with a global purpose: to create improved health and economic outcomes for the patients, healthcare providers and insurance organisations.

Receive BELL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Belluscura and its competitors with MarketBeat's FREE daily newsletter.

BELL Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com

BELL Stock Analysis - Frequently Asked Questions

Belluscura's stock was trading at GBX 8.81 at the beginning of the year. Since then, BELL shares have increased by 2.7% and is now trading at GBX 9.05.
View the best growth stocks for 2025 here
.

Shares of BELL stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
CIK
N/A
Phone
N/A
Fax
N/A
Employees
24
Year Founded
N/A

Profitability

Net Income
£-18,600,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£1.80 million
Cash Flow
GBX 1.13 per share
Book Value
GBX 12 per share

Miscellaneous

Free Float
N/A
Market Cap
£15.24 million
Optionable
Not Optionable
Beta
1.05
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (LON:BELL) was last updated on 1/18/2025 by MarketBeat.com Staff
From Our Partners